Allianz Asset Management
BMY.RT

Allianz Asset Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Allianz Asset Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,113
Closed -$7K – 2365
2020
Q4 		$7K Sell
10,113
-3,993
-28% -$8.51K ﹤0.01% 1836
2020
Q3 		$32K Sell
14,106
-4,081
-22% -$11.7K ﹤0.01% 1825
2020
Q2 		$65K Sell
18,187
-69,182
-79% -$250K ﹤0.01% 2356
2020
Q1 		$332K Sell
87,369
-102,280
-54% -$337K ﹤0.01% 2195
2019
Q4 		$570K Buy
+189,649
New +$493K ﹤0.01% 2395

Other funds holding BMY.RT

JCI
Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.61B AUM 22.15% 1-Year Est. Return
WAM
Westport Asset Management Southport, Connecticut $226M AUM 16.76% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.44B AUM 21.92% 1-Year Est. Return

Allianz Asset Management's BMY.RT Position: Q1 2021 in Review

Allianz Asset Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 10,113 shares — an estimated $7K sold.

Allianz Asset Management first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $570K in Q4 2019. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • Allianz Asset Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • Allianz Asset Management sold 10,113 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021, an estimated $7K.
  • Allianz Asset Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • Allianz Asset Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $570K in Q4 2019.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on Allianz Asset Management's 13F filing for Q1 2021, filed 13 May 2021.